Skip to main content
. 2022 Oct 4;12:16566. doi: 10.1038/s41598-022-20975-1

Table 2.

Disease characteristics of whole cohort.

N Total cohort Validation set Training set
2483 % 691 % 1415 %
Colorectal cancer 797 32.10 220 31.84 465 32.86
CRC-1 161 6.48 45 6.51 91 6.43
CRC-2 319 12.85 87 12.59 189 13.36
CRC-3 222 8.94 61 8.83 135 9.54
CRC-4 95 3.83 27 3.91 50 3.53
Other cancers
Advanced adenoma 306 12.32 82 11.87 169 11.94
Breast cancer 114 4.59 34 4.92 68 4.81
Lung cancer 140 5.64 51 7.38 80 5.65
Non-advanced adenoma 373 15.02 88 12.74 218 15.41
Ovarian cancer 32 1.29 10 1.45 15 1.06
Prostate cancer 91 3.66 25 3.62 50 3.53
Stomach cancer 32 1.29 8 1.16 21 1.48
Bladder cancer 25 1.01 9 1.30 13 0.92
Control
Standard 531 21.39 149 21.56 291 20.57
Rheumatoid arthritis 20 0.81 7 1.01 11 0.78
Peptic ulcer 12 0.48 6 0.87 6 0.42
COPD 10 0.40 2 0.29 8 0.57